Stock Code: 300702 Stock Abbreviation: Tianyu Shares Announcement No.: 2026-067
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Announcement Regarding the Proposed Selection of Wholly-Owned Subsidiary Products in the 12th National Centralized Drug Procurement
Zhejiang Tianyu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") and its wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical Co., Ltd., participated in the 12th national centralized drug procurement bidding organized by the Joint Procurement Office (hereinafter referred to as the "JPO"). According to the "Publicity of Proposed Selection Results for the 12th National Centralized Drug Procurement" released by the JPO on July 31, 2026, on the Shanghai Sunshine Medical Procurement Network (https://www.smpaa.cn), the Company's products, Trazodone Hydrochloride Tablets and Edoxaban Tosylate Tablets, have been proposed for selection in this centralized procurement. The relevant details are announced as follows: